Rhinosinusitis is a common disorder that ranges from acute to chronic, with GPs at the forefront of patient management. There have been recent developments in the understanding of this heterogeneous disease, and as such it is important that GPs are aware of the latest medical and surgical treatments that have evolved in order to better inform and manage patients under their care.
Rhinosinusitis is a common presenting complaint to primary care physicians. The term ‘rhinosinusitis’ describes a constellation of disease entities with a common feature – inflammation of the mucosa lining the nasal cavity and the paranasal sinuses. Rhinosinusitis is best characterised as acute, subacute, recurrent acute or chronic according to the duration of symptoms (Table). Acute rhinosinusitis (ARS) is estimated to affect between 6 and 15% of the population and a recent national health survey has shown that 10% of people in Australia suffer from chronic rhinosinusitis (CRS).1